+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
STAT Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

STAT Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
OX-40 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

OX-40 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Alpha-1 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha-1 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
T Cell Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

T Cell Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Inhibitor Of Apoptosis (IAP) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Inhibitor Of Apoptosis (IAP) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Bcl-xL Protein Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Bcl-xL Protein Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
RET (Ret Proto-Oncogene) protein Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

RET (Ret Proto-Oncogene) protein Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Histone deacetylase (HDAC) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Histone deacetylase (HDAC) Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
Akt1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Akt1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
NK Cell therapies - Pipeline Insight, 2024 - Product Thumbnail Image

NK Cell therapies - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
CAR T-cell Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 96 Pages
  • Global
From
Proto oncogene proteins c pim 1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene proteins c pim 1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more